QOL improves following superior lumiracoxib effect in OA

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.460, 2004-01, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QOL improves following superior lumiracoxib effect in OA

Inpharma, Vol. 1, Iss. 1452, 2004-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Alefacept improves QOL in psoriasis

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 399, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Erlotinib improves QOL in NSCLC

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 512, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Alosetron improves QOL in IBS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 308, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Antiepileptic substitution improves QOL

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 663, 2012-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite